Literature DB >> 28520953

Evolving Insights Into the Epidemiology and Control of Clostridium difficile in Hospitals.

Daniel A Caroff1,2, Deborah S Yokoe2, Michael Klompas1,2.   

Abstract

Typing studies suggest that most cases of hospital-onset Clostridium difficile infection (CDI) are unrelated to other cases of active disease in the hospital. New cases may instead be due to transmissions from asymptomatic carriers or progression of latent C. difficile present on admission to active infection. Direct exposure to antibiotics remains the primary risk factor for CDI but ward-level antibiotic use, antibiotic exposure of the prior room occupant, and C. difficile status of the prior room occupant increase risk for C. difficile acquisition while antibiotic exposure, gastric acid suppression, and immunosuppression increase risk for progression to infection. These insights suggest possible new approaches to prevent CDI, including screening to identify and isolate carriers, universal gloving, greater use of sporicidal cleaning methods, enhancing antibiotic and possibly proton pump inhibitor stewardship, and prescribing prophylactic vancomycin and/or probiotics to colonized patients to prevent progression from colonization to infection. We review current evidence and questions related to these interventions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28520953     DOI: 10.1093/cid/cix456

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Evaluation of the cobas Cdiff Test for Detection of Toxigenic Clostridium difficile in Stool Samples.

Authors:  Lance R Peterson; Stephen A Young; Thomas E Davis; Zi-Xuam Wang; John Duncan; Christopher Noutsios; Oliver Liesenfeld; John C Osiecki; Michael A Lewinski
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

2.  The Challenges of Tracking Clostridium difficile to Its Source in Hospitalized Patients.

Authors:  Justin J O'Hagan; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2019-01-07       Impact factor: 9.079

3.  Validation of Active Surveillance Testing for Clostridium difficile Colonization Using the cobas Cdiff Test.

Authors:  Parul A Patel; Donna M Schora; Kamaljit Singh; Lance R Peterson
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

4.  Screening of Clostridioides difficile carriers in an urban academic medical center: Understanding implications of disease.

Authors:  Sarah W Baron; Belinda E Ostrowsky; Priya Nori; David Y Drory; Michael H Levi; Wendy A Szymczak; Michael L Rinke; William N Southern
Journal:  Infect Control Hosp Epidemiol       Date:  2020-02       Impact factor: 3.254

5.  Factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI) in a Mexican tertiary care hospital: A case-control study.

Authors:  Eric Ochoa-Hein; José Sifuentes-Osornio; Alfredo Ponce de León-Garduño; Pedro Torres-González; Víctor Granados-García; Arturo Galindo-Fraga
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

6.  Genome-Based Comparison of Clostridioides difficile: Average Amino Acid Identity Analysis of Core Genomes.

Authors:  Adriana Cabal; Se-Ran Jun; Piroon Jenjaroenpun; Visanu Wanchai; Intawat Nookaew; Thidathip Wongsurawat; Mary J Burgess; Atul Kothari; Trudy M Wassenaar; David W Ussery
Journal:  Microb Ecol       Date:  2018-02-14       Impact factor: 4.552

7.  An Engineered Synthetic Biologic Protects Against Clostridium difficile Infection.

Authors:  Gayatri Vedantam; Joshua Kochanowsky; Jason Lindsey; Michael Mallozzi; Jennifer Lising Roxas; Chelsea Adamson; Farhan Anwar; Andrew Clark; Rachel Claus-Walker; Asad Mansoor; Rebecca McQuade; Ross Calvin Monasky; Shylaja Ramamurthy; Bryan Roxas; V K Viswanathan
Journal:  Front Microbiol       Date:  2018-09-05       Impact factor: 6.064

8.  Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients aged ≥60 years (EXTEND): analysis of cost-effectiveness.

Authors:  Oliver A Cornely; Maureen Watt; Charles McCrea; Simon D Goldenberg; Enrico De Nigris
Journal:  J Antimicrob Chemother       Date:  2018-09-01       Impact factor: 5.790

9.  Mathematically modeling the effect of touch frequency on the environmental transmission of Clostridioides difficile in healthcare settings.

Authors:  Cara Jill Sulyok; Lindsey Fox; Hannah Ritchie; Cristina Lanzas; Suzanne Lenhart; Judy Day
Journal:  Math Biosci       Date:  2021-07-24       Impact factor: 3.935

10.  Reduced Clostridioides difficile infection in a pragmatic stepped-wedge initiative using admission surveillance to detect colonization.

Authors:  Lance R Peterson; Sean O'Grady; Mary Keegan; Adrienne Fisher; Shane Zelencik; Bridget Kufner; Mona Shah; Rachel Lim; Donna Schora; Sanchita Das; Kamaljit Singh
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.